Neonatal hyperinsulinism after short-term maternal beta sympathomimetic therapy.
D000328:Adult; D000420:Albuterol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D013566:Sympathomimetics / Q000009:adverse effects* / Q000627:therapeutic use; D013726:Terbutaline / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D007328:Insulin; D013566:Sympathomimetics; D013726:Terbutaline; D000420:Albuterol